相关实验视频

Updated: Jun 8, 2025

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

如何避免错过神经脊髓炎光学谱系障碍的诊断

Edgar Carnero Contentti^1,2, Dalia Rotstein³, Darin T Okuda^4,5

¹Neuroimmunology Unit, Department of Neurosciences, Hospital Aleman, Buenos Aires, Argentina.

Multiple sclerosis (Houndmills, Basingstoke, England)

|November 6, 2024

概括

正确诊断神经髓炎光学谱系障碍 (NMOSD) 是至关重要的. 错误诊断,特别是在aquaporin-4-IgG-seronegative病例中,导致NMOSD患者的风险和延迟适当的治疗.

科学领域:

神经学神经学
免疫学免疫学免疫学
神经免疫学神经免疫学

背景情况:

神经脊髓炎光学谱系障碍 (NMOSD) 的识别和区分与多发性硬化症 (MS) 是具有挑战性的.
误诊的NMOSD是常见的,特别是在水-4-IgG (AQP4-IgG) 血清阴性个体.
不准确的诊断可能导致长期的,不必要的免疫治疗和增加患者的发病率.

研究的目的:

审查导致NMOSD误诊的因素.
为了强调准确的NMOSD诊断的重要性.
讨论减少NMOSD误诊率的策略.

主要方法:

关于与NMOSD误诊相关的因素的文献综述.
对NMOSD患者误诊率的分析.
讨论临床和神经放射学发现的解释.

主要成果:

对NMOSD的错误诊断率可能高达35%.
异质的临床表现和广泛的差异诊断有助于遗漏的NMOSD病例.
错误应用诊断标准和错误解释发现是关键因素.

结论:

准确的NMOSD诊断对于适当的治疗和改善患者结果至关重要.
减少错误诊断对于预防健康风险和残疾至关重要.
需要制定改善诊断准确性的策略.

关键词:

这就是为什么MRI是MRI.视神经炎 (NMO) 是指视神经炎.生物标志物生物标志物诊断诊断诊断诊断诊断诊断错误诊断是一个错误的诊断.

更多相关视频

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay

Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay

Published on: April 5, 2019

相关概念视频

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...